We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

461 hedge funds and large institutions have $9.45B invested in United Therapeutics in 2022 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 170 increasing their positions, 160 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more call options, than puts

Call options by funds: $104M | Put options by funds: $51M

2.74% more ownership

Funds ownership: 97.2% → 99.94% (+2.7%)

6% more repeat investments, than reductions

Existing positions increased: 170 | Existing positions reduced: 160

2% less funds holding

Funds holding: 472 → 461 (-11)

9% less capital invested

Capital invested by funds: $10.3B → $9.45B (-$878M)

11% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 61

25% less funds holding in top 10

Funds holding in top 10: 24 → 18 (-6)

Holders
461
Holders Change
-11
Holders Change %
-2.33%
% of All Funds
7.94%
Holding in Top 10
18
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-25%
% of All Funds
0.31%
New
54
Increased
170
Reduced
160
Closed
61
Calls
$104M
Puts
$51M
Net Calls
+$53.1M
Net Calls Change
+$3.64M

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$211M
2
Citadel Advisors
Citadel Advisors
Florida
+$124M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$63.7M
4
APM
Avidity Partners Management
Texas
+$54.7M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$36.6M

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$54.4M
2
PAMS
Pictet Asset Management (Switzerland)
Switzerland
-$41.7M
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$39M
4
American Century Companies
American Century Companies
Missouri
-$36.1M
5
First Trust Advisors
First Trust Advisors
Illinois
-$35.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
WCM
51
Wedge Capital Management
North Carolina
$34.7M +$1.22M +5,478 +3%
Lazard Asset Management
52
Lazard Asset Management
New York
$34.5M -$5.74M -25,677 -13%
Balyasny Asset Management
53
Balyasny Asset Management
Illinois
$33.5M +$12.3M +55,173 +53%
Russell Investments Group
54
Russell Investments Group
United Kingdom
$33.4M +$12.9M +57,828 +57%
Arrowstreet Capital
55
Arrowstreet Capital
Massachusetts
$31.8M -$5M -22,368 -13%
KCM
56
Kynam Capital Management
New Jersey
$31.6M +$33.8M +151,009 New
SI
57
Sofinnova Investments
California
$30.9M +$9.21M +41,185 +39%
PAMP
58
Polar Asset Management Partners
Ontario, Canada
$30.8M +$14.7M +65,900 +81%
EHI
59
Eagle Health Investments
Connecticut
$29.5M -$4.14M -18,500 -12%
PBA
60
Paradigm Biocapital Advisors
New York
$29.4M -$5.03M -22,505 -14%
VRS
61
Virginia Retirement Systems
Virginia
$28M +$29.9M +133,800 New
Retirement Systems of Alabama
62
Retirement Systems of Alabama
Alabama
$27.9M -$19.4K -87 -0.1%
RhumbLine Advisers
63
RhumbLine Advisers
Massachusetts
$27.9M +$821K +3,672 +3%
Macquarie Group
64
Macquarie Group
Australia
$26.6M -$129K -576 -0.5%
SAM
65
Storebrand Asset Management
Norway
$26.3M +$4.46M +19,950 +19%
PVI
66
Pura Vida Investments
New York
$26.2M +$14.4M +64,396 +106%
Man Group
67
Man Group
United Kingdom
$25.9M +$27.7M +123,815 New
TCM
68
Tekla Capital Management
Massachusetts
$24.6M +$10.1M +45,171 +63%
Legal & General Group
69
Legal & General Group
United Kingdom
$24.1M -$790K -3,535 -3%
Swiss National Bank
70
Swiss National Bank
Switzerland
$22.5M +$224K +1,000 +0.9%
TSW
71
Thompson Siegel & Walmsley
Virginia
$21.7M -$5.74M -25,664 -20%
California Public Employees Retirement System
72
California Public Employees Retirement System
California
$21.6M +$2.85M +12,731 +14%
EMFAT
73
Emerald Mutual Fund Advisers Trust
Pennsylvania
$21.5M -$6.9M -30,846 -23%
Acadian Asset Management
74
Acadian Asset Management
Massachusetts
$20.3M -$3.05M -13,623 -12%
EA
75
Emerald Advisers
Pennsylvania
$19.5M -$14.9M -66,840 -42%
1 2
3
4 5

UTHR Hedge Fund Activity: Q3 2022 in Review

461 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q3 2022, worth a combined $9.45B — down 8.5% from $10.3B a quarter earlier.

Sellers outnumbered buyers: 61 funds closed out of UTHR and 54 opened new positions — a net loss of 7 holders — while 160 trimmed existing stakes and 170 added.

The largest buyer was Janus Henderson Group, adding an estimated $211M. The largest seller was Renaissance Technologies, cutting an estimated $54.4M.

  • 461 institutional investors held United Therapeutics (UTHR) as of Q3 2022, down from 472 in Q2 2022.
  • Funds reported $9.45B of United Therapeutics stock for Q3 2022, down 8.5% quarter-over-quarter.
  • 54 funds opened new United Therapeutics positions in Q3 2022 and 61 closed out, a net change of -7 holders.
  • The largest United Therapeutics buyer in Q3 2022 was Janus Henderson Group, an estimated $211M added.
  • The largest United Therapeutics seller in Q3 2022 was Renaissance Technologies, an estimated $54.4M sold.

Based on aggregated 13F filings for Q3 2022.